Skip to main content
. 2017 Jun 14;42(11):2114–2127. doi: 10.1038/npp.2017.86

Table 1. Receptor Interaction Profiles for LSD and Other Classic Serotonergic Hallucinogens at Human Receptors.

    LSDa Psilocinb DMTb Mescalinea
5-HT1A Receptor binding Ki±SD (μM) 0.003±0.0005 0.123±0.02 0.075±0.02 4.6±0.4
5-HT2A Receptor binding Ki±SD (μM) 0.004±0.001 0.049±0.01 0.237±0.04 6.3±1.8
5-HT2A Activation potency EC50±SD (μM) 0.261±0.15 0.721±0.55 0.076±0.03 10±1.8
5-HT2A Activation efficacy % maximum±SD 28±10 16±8 40±11 56±15
5-HT2B Activation potency EC50±SD (μM) 12±0.4 >20 3.4±3.2 >20
5-HT2B Activation efficacy % maximum±SD 71±31   19±6  
5-HT2C Receptor binding Ki±SD (μM) 0.015±0.003 0.094±0.009 0.424±0.15 17±2.0
α2A Receptor binding Ki±SD (μM) 0.67±0.18 6.7±1.1 1.3±0.2 >15
α1A Receptor binding Ki±SD (μM) 0.012±0.002 2.1±0.01 2.1±0.4 1.4±0.2
D1 Receptor binding Ki±SD (μM) 0.31±0.09 >14 6.0±0.9 >14
D2 Receptor binding Ki±SD (μM) 0.025±0.0004 3.7±0.6 3.0±0.4 >10
D3 Receptor binding Ki±SD (μM) 0.10±0.01 8.9±0.8 6.3±2.1 >17
H1 Receptor binding Ki±SD (μM) 1.1±0.2 1.6±0.2 0.22±0.03 >25
TAAR1c Activation potency EC50±SD (μM) >20 >30 >10 >10
NET Receptor binding Ki±SD (μM) >30 13±1.7 6.5±1.3 >30
NET Inhibition potency IC50 (μM) (95% CI) >100 14 (10–19) 3.9 (2.8–5.3) >100
DAT Receptor binding Ki±SD (μM) >30 >30 22±3.9 >30
DAT Inhibition potency IC50 (μM) (95% CI) >100 >100 52 (37–72) >100
SERT Receptor binding Ki±SD (μM) >30 6.0±0.3 6.0±0.6 >30
SERT Inhibition potency IC50 (μM) (95% CI) >100 3.9 (3.1–4.8) 3.1 (2.4–4.0) >100
Dosed Mg 0.1 12 40 300

Abbreviations: DAT, dopamine transporter; NET, norepinephrine transporter; SERT, serotonin transporter.

All data were generated using the same assays across substances to allow for direct comparisons.

d

Estimated average psychoactive dose in humans from Passie et al, 2008 and Nichols, 2004.